logo
French surgeon handed maximum sentence in mass child-abuse trial

French surgeon handed maximum sentence in mass child-abuse trial

Miami Herald5 days ago

PARIS - A former French surgeon was sentenced to 20 years in prison on Wednesday after having confessed to the abuse of 299 patients, most of them minors.
In what is considered to be France's largest child-abuse trial, retired medical doctor Joël Le Scouarnec, 74, admitted to abusing a total of 158 male and 141 female patients with an average age of 11 between 1989 and 2014.
Prosecutors had accused the defendant of having treated his victims like lifeless objects, showing no empathy whatsoever, and exploiting his position as a doctor.
He often abused patients who were still under anaesthetic or children who were unable to classify his actions as abuse.
The public prosecutor had demanded a 20-year prison sentence, the maximum possible penalty for the defendant.
It said the number of victims was higher still. So as not to delay the trial, 299 cases were initially brought to court. There would probably be further criminal proceedings for other victims.
State of shock
The case has shocked France, and questions have been raised as to why the health authorities were unable to stop the doctor earlier, as he had been given a suspended sentence for child pornography in 2005.
The defence lawyer spoke of "a major failure" of France's health systems. He said that indications of misconduct had been trivialized and that the authorities had preferred to keep the doctor in his post.
Victims of the surgeon also denounced the failure of the authorities.
"How was Doctor Scouarnec able to practise for 30 years, how was he allowed to go about his business, why didn't anyone know?" a 36-year-old woman asked in court.
France's medical association admitted its own failings in the trial.
The doctor had been sentenced to 15 years in prison for four cases of abuse in 2020. The investigation was triggered in 2017 by a complaint from a neighbour whose 6-year-old daughter was abused by the doctor in the garden.
During searches, the investigators came across around 300,000 photos of child abuse as well as diaries in which the doctor had recorded his decades of abuse in great detail. With this information, the investigators set out to find the often unknowing victims that the surgeon met during his work in rural hospitals in western France.
Traumatized victims
Numerous victims spoke in court about the trauma and psychological damage caused by the abuse. Children who had not been aware of the abuse had also reacted subconsciously to the violence they suffered.
Experts diagnosed post-traumatic syndromes, inhibitions and physical complaints in the victims as a result of psychological stress.
In some cases, these only materialized after the investigators visited the victims and revealed to them that they had been abused in their childhood.
At the start of the trial, the retired doctor gave a comprehensive confession. "I committed heinous acts," he said. "I must bear the responsibility for my actions and the consequences for the victims, which they will carry for the rest of their lives."
Unexpectedly, the doctor later admitted in court that he had also abused his granddaughter, who at the time was 2 years old.
Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

French police detain dozens after football celebrations
French police detain dozens after football celebrations

Yahoo

time29 minutes ago

  • Yahoo

French police detain dozens after football celebrations

French authorities detained 79 people in the second such wave of arrests during celebrations following Paris Saint-Germain's football Champions League win, a police chief said Monday. The PSG thrashed Inter Milan by a record 5-0 in Saturday evening's final in Munich, flying back to Paris on Sunday for a triumphal parade along the Champs Elysees, then celebrations in a packed Parc des Princes stadium on the edge of the French capital. The PSG winning the biggest prize in European club football for the first time sparked delirious festivities in France, but was marred by violence. On Sunday, "we saw a resurgence of individuals driven by malicious intent who were not really PSG supporters," Paris police chief Laurent Nunez told RTL radio. "We arrested 79 people, some of them in the night," he said, adding that order had been restored before dawn. Some were detained over taking barriers and briefly blocking the ring road around Paris, while others had tried to vandalise businesses or fired fireworks on the Champs Elysees, he said. On Saturday night, police had made more than 500 arrests across France, the interior ministry said, after more than 200 cars were torched and police clashed with youths. In the southwest town of Dax, a 17-year-old boy died after being stabbed in the chest. A 23-year-old man riding a scooter in central Paris also died after being hit by a vehicle. A policeman was in an induced coma after being injured by a firework. Receiving the triumphant team at the Elysee palace on Sunday, French President Emmanuel Macron condemned what he called "unacceptable" violence during the festivities. Many of the stars of the team, one of the youngest in the competition, are drawn from the huge football talent pool in the Paris suburbs after PSG's Qatari owners turned their back on the policy of signing star players like Neymar and Lionel Messi. A total of 11.5 million people tuned in across France to watch the match. mca/ah/yad

CARMAT Announces the First Commercial Implants of Its Aeson® Artificial Heart Outside the European Union
CARMAT Announces the First Commercial Implants of Its Aeson® Artificial Heart Outside the European Union

Business Wire

time4 hours ago

  • Business Wire

CARMAT Announces the First Commercial Implants of Its Aeson® Artificial Heart Outside the European Union

PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the ' Company ' or ' CARMAT '), today announces the first implants of its Aeson® artificial heart in a commercial set-up, outside the European Union (EU). Two implants of Aeson® artificial heart were performed during the week commencing May 26, 2025 in Israel. The first one was carried out at Hadassah Ein Kerem Hospital in Jerusalem by a team led by Pr Offer Amir, Pr Rabea Asleh and Dr Amit Korach, respectively director of the Heart Institute, director of heart failure unit and director of the cardiac surgery department at Hadassah Medical Center. The second one was carried out at Sheba Medical Center in Ramat Gan (Tel Aviv), by a team led by Dr Jeff Morgan, Dr Leonid Sternik, Dr Alex Fardman and Dr Eyal Nachum, respectively head of mechanical support unit, director of cardiac surgery department, heart failure cardiologist and cardiac transplant surgeon. Those are the first Aeson® implants made in a commercial set-up outside the European Union. These implants bring to 5 the total number of countries 1 where commercial implants have been performed so far. They confirm the trust placed in the device by healthcare professionals, and the growing interest in the therapy. About CARMAT CARMAT is a French MedTech that designs, manufactures and markets the Aeson ® artificial heart. The Company's ambition is to make Aeson ® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world's first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson ® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson ® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson ® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States. Founded in 2008, CARMAT is based in the Paris region, with its head offices located in Vélizy-Villacoublay and its production site in Bois-d'Arcy. The Company can rely on the talent and expertise of a multidisciplinary team of circa 200 highly specialized people. CARMAT is listed on the Euronext Growth market in Paris (Ticker: ALCAR / ISIN code: FR0010907956). For more information, please go to and follow us on LinkedIn. Disclaimer This press release and the information it contains do not constitute an offer to sell or subscribe, nor a solicitation of an offer to buy or subscribe, for CARMAT shares in any country. This press release may contain forward-looking statements regarding the Company's objectives and outlook. These forward-looking statements are based on the current estimates and anticipations of the Company's management and are subject to risk factors and uncertainties, including those described in its Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers) (the 'AMF') under number D.25-0345 (the ' 2024 Universal Registration Document '), available free of charge on the websites of CARMAT ( and the AMF ( Readers' attention is particularly drawn to the fact that the Company's current cash runway is limited to mid-June 2025 (excluding the flexible equity financing line entered into with IRIS, which was announced on March 27, 2025). The Company is also subject to other risks and uncertainties, such as its ability to implement its strategy, the pace of development of its production and sales, the pace and results of ongoing or planned clinical trials, technological evolution and competitive environment, regulatory changes, industrial risks, and all risks associated with the Company's growth management. The Company's forward-looking statements mentioned in this press release may not be achieved due to these elements or other risk factors and uncertainties, whether unknown or not considered material and specific by the Company as of today. Aeson® is an active implantable medical device commercially available in the European Union and other countries recognising the CE mark. The Aeson® total artificial heart is intended to replace the ventricles of the native heart and is indicated as a bridge to transplant in patients with end-stage biventricular heart failure (Intermacs classes 1-4) who cannot benefit from maximal medical therapy or a left ventricular assist device (LVAD) and who are likely to benefit from a heart transplant within 180 days of implantation. The decision to implant and the surgical procedure must be carried out by healthcare professionals trained by the manufacturer. The documentation (clinician's manual, patient's manual and alarm booklet) must be read carefully to learn about the characteristics of Aeson® and the information required for patient selection and proper use (contraindications, precautions, side effects) of Aeson®. In the United States, Aeson® is currently only available as part of a feasibility clinical trial approved by the Food & Drug Administration (FDA).

2 dead, hundreds injured in chaos after Paris Saint-Germain win
2 dead, hundreds injured in chaos after Paris Saint-Germain win

Yahoo

time12 hours ago

  • Yahoo

2 dead, hundreds injured in chaos after Paris Saint-Germain win

June 1 (UPI) -- At least two people have died, and hundreds were reported injured, in the chaotic aftermath of Paris Saint-Germain's victory against Inter Milan at the Champions League final in Munich on Saturday. The French Interior Ministry confirmed in an emailed statement to UPI that two people had died and 192 people were injured overnight Saturday. In total, 559 arrests were made, including 491 people in Paris. The chaos also led to the injury of 22 police officers and seven firefighters, the Interior Ministry said. There were 692 fire incidents recorded, including some 264 burning cars. PSG had defeated Inter Milan 5-0, marking the team's first championship win and the first time a French team had won in more than three decades. "All over France last night, numerous police and firefighters were injured as they intervened to restore public order and provide assistance during the Paris Saint-Germain victory celebrations," French National Police spokesperson Agathe Foucault said in a statement. "In Coutances, Manche, a police officer from the canine brigade was hit in the eye by a firework mortar. He is currently hospitalized in a serious condition. Thoughts and best wishes for a speedy recovery to all our colleagues." The deaths included a 17-year-old boy who was stabbed in the chest in the southern town of Dax and a 23-year-old man who was hit by a car while riding his scooter in central Paris, The New York Times reported. Bruno Retailleau, the French interior minister, called rioters "barbarians" in comments to social media.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store